138 related articles for article (PubMed ID: 30318927)
1. Improving LARC Access for Urban Adolescents and Young Adults in the Pediatric Primary Care Setting.
Onyewuchi UF; Tomaszewski K; Upadhya KK; Gupta PS; Whaley N; Burke AE; Trent ME
Clin Pediatr (Phila); 2019 Jan; 58(1):24-33. PubMed ID: 30318927
[TBL] [Abstract][Full Text] [Related]
2. How Long-Acting Reversible Contraception Knowledge, Training, and Provider Concerns Predict Referrals and Placement.
Thompson CM; Broecker J; Dade M
J Am Osteopath Assoc; 2019 Nov; 119(11):725-734. PubMed ID: 31657827
[TBL] [Abstract][Full Text] [Related]
3. Access to long-acting reversible contraception among US publicly funded health centers.
Bornstein M; Carter M; Zapata L; Gavin L; Moskosky S
Contraception; 2018 May; 97(5):405-410. PubMed ID: 29253581
[TBL] [Abstract][Full Text] [Related]
4. Can Pediatricians Provide Long-Acting Reversible Contraception?
Norris AH; Pritt NM; Berlan ED
J Pediatr Adolesc Gynecol; 2019 Feb; 32(1):39-43. PubMed ID: 30278228
[TBL] [Abstract][Full Text] [Related]
5. Pediatric Practice Transformation and Long-Acting Reversible Contraception (LARC) Use in Adolescents.
Schiavoni KH; Lawrence J; Xue J; Kotelchuck M; Boudreau AA
Acad Pediatr; 2022 Mar; 22(2):296-304. PubMed ID: 34758402
[TBL] [Abstract][Full Text] [Related]
6. The Impact of an Adolescent Gynecology Provider on Intrauterine Device and Subdermal Contraceptive Implant Use Among Adolescent Patients.
Crain CL; DeFruscio AE; Shah PT; Hunt L; Yoost JL
J Pediatr Adolesc Gynecol; 2020 Aug; 33(4):377-381. PubMed ID: 32087404
[TBL] [Abstract][Full Text] [Related]
7. Availability of long-acting reversible contraceptives in Los Angeles County clinics through a Medicaid state plan amendment program.
Natavio M; Blotky E; Van Horn CM; Waters C; Ihenacho U; Silverstein E; Cortessis VK; Nelson AL
Contraception; 2018 Dec; 98(6):471-475. PubMed ID: 30076832
[TBL] [Abstract][Full Text] [Related]
8. Mentoring, Task Sharing, and Community Outreach Through the TutoratPlus Approach: Increasing Use of Long-Acting Reversible Contraceptives in Senegal.
Gueye B; Wesson J; Koumtingue D; Stratton S; Viadro C; Talla H; Dioh E; Cissé C; Sebikali B; Mamadou Daff B
Glob Health Sci Pract; 2016 Aug; 4 Suppl 2(Suppl 2):S33-43. PubMed ID: 27540123
[TBL] [Abstract][Full Text] [Related]
9. Provider and Health System Factors Associated with Usage of Long-Acting Reversible Contraception in Adolescents.
Smith AJB; Harney KF; Singh T; Hurwitz AG
J Pediatr Adolesc Gynecol; 2017 Dec; 30(6):609-614. PubMed ID: 28502827
[TBL] [Abstract][Full Text] [Related]
10. Health Care Provider Attitudes about the Safety of "Quick Start" Initiation of Long-Acting Reversible Contraception for Adolescents.
Morgan IA; Zapata LB; Curtis KM; Whiteman MK
J Pediatr Adolesc Gynecol; 2019 Aug; 32(4):402-408. PubMed ID: 30731216
[TBL] [Abstract][Full Text] [Related]
11. Pediatric Provider Education and Use of Long-Acting Reversible Contraception in Adolescents.
Smith AJB; Hurwitz AG; Singh T; Harney KF
J Pediatr Health Care; 2019; 33(2):146-152.e1. PubMed ID: 30228031
[TBL] [Abstract][Full Text] [Related]
12. Health Care Barriers to Provision of Long-Acting Reversible Contraception in Wisconsin.
Olson EM; Kramer RD; Gibson C; Wautlet CK; Schmuhl NB; Ehrenthal DB
WMJ; 2018 Oct; 117(4):149-155. PubMed ID: 30407764
[TBL] [Abstract][Full Text] [Related]
13. Evaluating a LARC Expansion Program in 14 Sub-Saharan African Countries: A Service Delivery Model for Meeting FP2020 Goals.
Ngo TD; Nuccio O; Pereira SK; Footman K; Reiss K
Matern Child Health J; 2017 Sep; 21(9):1734-1743. PubMed ID: 27154524
[TBL] [Abstract][Full Text] [Related]
14. Implementation of Recommendations for Long-Acting Contraception Among Women Aged 13 to 18 Years in Primary Care.
Arnold Rehring SM; Reifler LM; Seidel JH; Glenn KA; Steiner JF
Acad Pediatr; 2019 Jul; 19(5):572-580. PubMed ID: 30959224
[TBL] [Abstract][Full Text] [Related]
15. Facilitators and Barriers to Implementation of Long-Acting Reversible Contraceptive Services for Adolescent Girls and Young Women in Gaborone, Botswana.
Henry D; Wood S; Moshashane N; Ramontshonyana K; Amutah C; Maleki P; Howlett C; Brooks MJ; Mussa A; Joel D; Steenhoff AP; Akers AY; Morroni C
J Pediatr Adolesc Gynecol; 2021 Aug; 34(4):504-513. PubMed ID: 33766793
[TBL] [Abstract][Full Text] [Related]
16. Adherence to Recommended Practices for Provision of Long-Acting Reversible Contraception Among Providers in a Large U.S. Health Care System.
Judge-Golden CP; Wiesenfeld HC; Chen BA; Borrero S
J Womens Health (Larchmt); 2020 Dec; 29(12):1586-1595. PubMed ID: 32667847
[No Abstract] [Full Text] [Related]
17. Final Program Data and Factors Associated With Long-Acting Reversible Contraception Removal: The Zika Contraception Access Network.
Lathrop E; Hurst S; Mendoza Z; Zapata LB; Cordero P; Powell R; Green C; Moreno N; Jamieson DJ; Romero L
Obstet Gynecol; 2020 May; 135(5):1095-1103. PubMed ID: 32282596
[TBL] [Abstract][Full Text] [Related]
18. An Evaluation of Contraceptive Methods After Implementation of a Novel LARC Program in a Residency Primary Care Clinic.
Gopinath VV; Monteiro JFG; Carr A; Sobota M; Geary M; McGarry K
R I Med J (2013); 2022 Apr; 105(3):57-59. PubMed ID: 35349624
[TBL] [Abstract][Full Text] [Related]
19. Influences on Intentions to Place Long-Acting Reversible Contraceptives: A Pilot Study Comparing According to Provider Specialty in Ohio.
Thompson CM; Broecker J; Dade M; Nottingham K
J Pediatr Adolesc Gynecol; 2018 Oct; 31(5):509-515. PubMed ID: 29580916
[TBL] [Abstract][Full Text] [Related]
20. Long-Acting Reversible Contraception Counseling and Use for Older Adolescents and Nulliparous Women.
Gibbs SE; Rocca CH; Bednarek P; Thompson KMJ; Darney PD; Harper CC
J Adolesc Health; 2016 Dec; 59(6):703-709. PubMed ID: 27665153
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
